Eli Lilly, Alzheimer and FDA
As Alphabet looks to fill a vacancy in its senior ranks, it’s turning to a longtime Eli Lilly veteran who helped build the ...
Eli Lilly & Co.’s hefty investment in expanding production capacity for its popular weight-loss and diabetes drugs is ...
Doctors prescribe Lilly's Mounjaro and Zepbound to help patients manage their weight, and the results have been fantastic.
Eli Lilly CFO Anat Ashkenazi will become Alphabet's new chief financial officer effective July 31, Google's parent company ...
Ashkenazi will succeed Ruth Porat, who was previously named president and chief investment officer.
Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.
In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other quality stocks. Investing in 2024 is significantly different from investing in the ...
Eli Lilly's blockbuster drug Mounjaro has been approved in China, resulting in high demand and strong earnings. See why I ...
10d
W eight-loss drugs have made big headlines in health over the past year, and Eli Lilly’s drug tirzepatide (known as Zepbound ...
Alphabet has announced who its new chief financial officer (CFO) will be, revealing today that it has hired pharmaceutical ...
LLY has been on a tear, with their stock price hitting all-time highs recently and closing the week at around $820. However, ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Eledon Pharmaceuticals (ELDN – Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results